These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7267481)

  • 21. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
    Gonska BD; Kreuzer H
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
    Walter U; Cordes U; Philipp T; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():311-4. PubMed ID: 347804
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension.
    Backhouse CI; Rowley-Jones D; Spencer-Mills L
    Curr Med Res Opin; 1986; 10(3):196-202. PubMed ID: 3731824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma electrolytes in elderly patients taking fixed combination diuretics.
    Bayer AJ; Farag R; Browne S; Pathy MS
    Postgrad Med J; 1986 Mar; 62(725):159-62. PubMed ID: 3714599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction.
    Knowles SR; Wong GA; Rahim SA; Binkley K; Phillips EJ; Shear NH
    Pharmacotherapy; 2005 Sep; 25(9):1258-65. PubMed ID: 16164399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
    Hollenberg NK; Mickiewicz C
    Arch Intern Med; 1989 Jun; 149(6):1327-30. PubMed ID: 2730251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum and total body potassium during treatment with chlortalidone and hydrochlorothiazide. Influence of triamterene (author's transl)].
    Schäfer GE; Werner E; Kober G; Kaltenbach M
    Dtsch Med Wochenschr; 1977 Dec; 102(50):1838-43. PubMed ID: 590117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption and disposition of two combination formulations of hydrochlorothiazide and triamterene: influence of age and renal function.
    Williams RL; Thornhill MD; Upton RA; Blume C; Clark TS; Lin E; Benet LZ
    Clin Pharmacol Ther; 1986 Aug; 40(2):226-32. PubMed ID: 3731685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
    Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
    Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium-sparing effects of triamterene in the treatment of hypertension.
    Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
    Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum potassium concentrations after initiation of captopril therapy.
    Schuna AA; Schmidt GR; Pitterle ME
    Clin Pharm; 1986 Nov; 5(11):920-3. PubMed ID: 3536269
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancing the efficacy of lithium treatment by combined use with diuretics and low sodium diets: a preliminary report.
    Maletzky BM
    J Clin Psychiatry; 1979 Jul; 40(7):317-22. PubMed ID: 378986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyazide composition.
    Akman D
    Ann Intern Med; 1976 Dec; 85(6):827. PubMed ID: 999119
    [No Abstract]   [Full Text] [Related]  

  • 36. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
    Inoue M; Nakai K; Mitsuiki K
    CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potassium-sparing diuretics: interaction with digoxin in elderly men.
    Finnegan TP; Spence JD; Cape RD
    J Am Geriatr Soc; 1984 Feb; 32(2):129-31. PubMed ID: 6363492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure.
    Funke Küpper AJ; Fintelman H; Huige MC; Koolen JJ; Liem KL; Lustermans FA
    Eur J Clin Pharmacol; 1986; 30(3):341-3. PubMed ID: 3732372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient conversion of treatment to potassium-sparing diuretics.
    Ridgeway NA; Ginn DR; Alley K
    Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.